Achillion Pharmaceuticals, Inc.
(NASDAQ : ACHN)

( )
ACHN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
1.43%89.631.3%$877.94m
AMGNAmgen Inc.
0.40%191.891.2%$550.47m
GILDGilead Sciences, Inc.
0.50%64.920.9%$461.62m
BIIBBiogen Inc.
-29.23%226.881.3%$457.10m
ONCESpark Therapeutics, Inc.
-0.20%113.2711.2%$443.03m
REGNRegeneron Pharmaceuticals, Inc.
-0.72%402.592.6%$280.51m
ILMNIllumina, Inc.
1.24%319.213.5%$280.06m
VRTXVertex Pharmaceuticals Incorporated
1.43%182.561.9%$232.81m
SRPTSarepta Therapeutics, Inc.
2.27%126.6615.4%$211.90m
EXASExact Sciences Corporation
1.70%92.0225.3%$191.93m
ALXNAlexion Pharmaceuticals, Inc.
1.94%134.212.0%$186.57m
BPTHBio-Path Holdings, Inc.
-14.05%18.48190.1%$182.12m
AAgilent Technologies, Inc.
1.34%82.001.6%$143.35m
IONSIonis Pharmaceuticals, Inc.
0.36%80.508.3%$105.13m
BMRNBioMarin Pharmaceutical Inc.
0.91%90.784.3%$95.05m

Company Profile

Achillion Pharmaceuticals, Inc. engages in the discovery and development of small molecule drug therapies for immune system disorders. It offers its propriety platform of potent and specific complement factor D inhibitors for AP-mediated diseases. The company was founded on August 17, 1998 and is headquartered in New Haven, CT.